Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-23-000805
Filing Date
2023-01-10
Accepted
2023-01-10 08:58:05
Documents
1
Period of Report
2023-01-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167335907130095.html 4  
1 FORM 4 wf-form4_167335907130095.xml 4 4600
  Complete submission text file 0001628280-23-000805.txt   5999
Mailing Address C/O STONINGTON PARTNERS, INC. 540 MADISON AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address
Bartholdson John A. (Reporting) CIK: 0001382909 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37844 | Film No.: 23519777

Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Issuer) CIK: 0001665988 (see all company filings)

EIN.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus